Biotech Legislative Agenda: Healthcare, Energy, Patents And Capital 05/10/2009 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment The United States Congress and biotechnology industry are currently focused on healthcare reform, but biotech is also looking to the future at energy reform, patent reform and other intellectual property-related legislative priorities still on its agenda.
Access To Safe Medicine A Public Health Issue, Not IP, Says Panel 04/10/2009 by Catherine Saez, Intellectual Property Watch 2 Comments Anti-counterfeiting initiatives might have a negative impact on access to medicines while not addressing the problem of fake medicines, particularly in developing countries, according to panellists at a recent event organised by the Open Society Institute.
Second HADOPI Law Faces French Constitutionality Test 02/10/2009 by Catherine Saez, Intellectual Property Watch 1 Comment Just days after the French Parliament adopted a bill aiming to protect literary and artistic intellectual property rights online on 25 September; the law is being challenged on constitutionality grounds.
US Industry Campaign: IP Needed To Address Climate Change, Economy 02/10/2009 by Catherine Saez, Intellectual Property Watch 1 Comment Intellectual property rights are a key to innovation, the mitigation of climate change, an incentive to spur the economy and a creator of jobs, according to participants in several recent industry events and activities.
Third Revision of Patent Law in China (Part II) 01/10/2009 by Intellectual Property Watch 4 Comments The third amendment of Chinese Patent Law enters into force from 1 October, 2009. This article by Wenting Cheng explores the major changes in substantive requirements for patent grant, post-grant enforcement and adaptation of Chinese Patent Law to international norms on the protection of intellectual property.
Global Oversight For Internet; US Role In Core Infrastructure Unchanged 01/10/2009 by Monika Ermert for Intellectual Property Watch 3 Comments A mere “affirmation of commitments” (AoC) between the Internet Corporation for Assigned Names and Numbers (ICANN) and the United States Department of Commerce has replaced the decade-old joint project agreement in place in different forms since ICANN started technical coordination of names and numbers on the net in 1998.
Regulators’ Role Seen Rising As E-Content Tied To Devices 29/09/2009 by Dugie Standeford for Intellectual Property Watch 5 Comments When Amazon.com remotely deleted George Orwell’s “1984″ and “Animal Farm” from its Kindle e-books, it stirred up a hornet’s nest of complaints about privacy, the potential erosion of copyright users’ rights and censorship. Is the shift to “tethered devices” a real cause for concern or much ado about nothing?
ICANN’s New US Contract And New Top Level Domains – It’s Not Over 29/09/2009 by Monika Ermert for Intellectual Property Watch 2 Comments With a day to go before the joint project agreement between the Internet Corporation for Assigned Names and Numbers (ICANN) and the United States Department of Commerce (DoC) is set to expire, calls for continuous US oversight role have been reiterated by US politicians and private-sector representatives who reason that this oversight is especially needed in the face of the planned introduction of new internet top-level domains like .shop.
US Acts To Preserve Internet Neutrality; European Debate Heats Up 24/09/2009 by Liza Porteus Viana, Intellectual Property Watch 1 Comment As the United States is moving to ensure that internet (net) neutrality is preserved in that country, some are hoping other regions of the world will take notice, particularly the European Union.
Candidates For EPO President On Campaign Trail At WIPO Conference 21/09/2009 by William New, Intellectual Property Watch Leave a Comment A recent two-day conference of the World Intellectual Property Organization on IP infrastructure also served as a campaign platform of sorts for several candidates vying to be the next head of the European Patent Office in Munich starting in mid-2010.